AF
PYXS icon

Allworth Financial’s Pyxis Oncology PYXS Stock Holding History

Allworth Financial’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-200
Closed -$852 – 3776
2024
Q1 		$852 Hold
200
– – ﹤0.01% 3131
2023
Q4 		$360 Hold
200
– – ﹤0.01% 3200
2023
Q3 		$398 Hold
200
– – ﹤0.01% 3092
2023
Q2 		$512 Buy
+200
New +$634 ﹤0.01% 2893

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allworth Financial's PYXS Position: Q2 2024 in Review

Allworth Financial sold out of Pyxis Oncology (PYXS) in Q2 2024, closing a stake of 200 shares — an estimated $852 sold.

Allworth Financial first reported a position in PYXS in Q2 2023 and held it in 4 quarters. The position peaked at $852 in Q1 2024. 80 funds tracked by Wall St. Rank hold PYXS as of Q2 2024.

  • Allworth Financial reported no remaining Pyxis Oncology position as of Q2 2024 after selling out during the quarter.
  • Allworth Financial sold 200 Pyxis Oncology shares in Q2 2024, an estimated $852.
  • Allworth Financial first reported a position in Pyxis Oncology in Q2 2023 and held it in 4 quarters.
  • Allworth Financial's Pyxis Oncology position peaked at $852 in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2024.

Based on Allworth Financial's 13F filing for Q2 2024, filed 24 Jul 2024.